Fujii Y et al. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8
Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
Matsuoka Y et al. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
Matsuoka Y et al. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8
Matsuoka Y et al. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9
Ishioka J et al. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8
Ishioka J et al. Yokoyama M., Kawamura N., Fujii Y., Inoue M., Ishioka J., Numao N., Matsuoka Y., Saito K., Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal renal function recovery after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8
Yoshida S et al. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9
Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9
Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Nakamura Y et al. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
Nakamura Y et al. High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
Fujiwara M et al. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Prognostic significance of postoperative skeletal muscle mass recovery in metastatic renal cell carcinoma patients who underwent cytoreductive nephrectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7
Nakanishi Y, Fukushima H, Yokoyama M, Kataoka M, Tobisu K, Koga F. Can systematic biopsy be safely omitted in the era of MRI/TRUS-fusion targeted prostate biopsy? The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6
